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ABSTRACT 
The relationship between high fish consumption and low mortality following coronary heart disease 
(CHD) and low incidence of breast cancer was first mentioned 3 decades ago. The fishes of interest 
are rich in omega-3 long-chain polyunsaturated fatty acids (-3 LC-PUFAs), especially 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which could be the active nutrients. 
The current consensus about cardioprotection is that -3 LC-PUFAs would mainly exert 
antiarrhythmic effects. One of the proposed mechanisms is that circulating non esterified LC-
PUFAs partition into cardiac cells membrane phospholipids and exert a direct effect on ionic 
channels and/or modify intracellular calcium homeostasis. In another hypothesis, changes in the 
metabolism of phosphoinositides would be involved and lead to the differential activation of PKC 
isoforms. As compared to the mechanisms proposed for the cardioprotective effects of omega-3 LC-
PUFAs, less is known about the molecular mechanisms involved in breast cancers prevention. 
Some proposed mechanisms such as the modulation of phosphoinositides metabolism and/or 
modulation of intracellular calcium homeostasis, are common to both pathologies. Other hypotheses 
involve the alteration of the cellular redox status induced by highly peroxidizable polyunsaturated 
fatty acids, or the modulation of gene expression, both phenomena being tightly linked to apoptosis. 
In this review, we report and compare some proposed mechanisms for the involvement of omega-3 
LC-PUFAs in both cardiac and breast cancer protection. Deliberately, we chose to discuss only the 
mechanisms which are less described in other reviews such as ionic channels in cancer, calcium 
homeostasis, PKC activation or matrix metalloproteinases in both cancer and cardiac models. The 
leitmotiv along this review is that cardio- and cancero- protective effects use common pathways. 
Comparison of the cellular effects might therefore help to highlight the "protective" pathways. 
 
 
Keywords: breast cancer, coronary heart disease, omega-3 polyunsaturated fatty acids, signalling 
pathways. 
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INTRODUCTION 
 
The inverse relationship between high fish consumption and low mortality following CHD 
or breast cancer was first mentioned 3 decades ago. The fishes of interest are mainly oily fishes (e.g. 
wild salmon, sardines, mackerel) which are rich in omega 3 (-3) LC-PUFAs. The two fatty acids 
(FA) which are very likely to be involved in the beneficial effects of fish oils are eicosapentaenoic 
acid (EPA, C20:5n-3) and docosahexaenoic acid (DHA, C22:6n-3). These FA are produced by 
monocellular algae or phytoplankton which represent the beginning of the food chain, and 
accumulate in the flesh of marine fishes. In this review, we do not address the field of alpha-
linolenic acid since this fatty acid has a vegetable and not marine origin. 
The first evidence for cancer- and CHD-protective effects of fish consumption came from 
epidemiological studies on Inuit and Japanese populations which, in their country of origin, mainly 
eat fish (Buell, 1973; Bang et al., 1976). When these populations migrated and adopted the local 
food habits, the disease incidence increased to reach the one of the local populations, ruling out 
genetic protection. 
It is well known that the effects of -3 PUFAs are generally opposite to those of -6 PUFAs 
(mainly arachidonic acid, AA: C20:4n-6). They compete for the same cyclooxygenase, 
lipoxygenase and epoxygenase enzymes to form different classes of eicosanoids. Members of each 
class have opposite effects, depending on the initial substrate, -3 or -6 LC-PUFAs (Weber et al., 
1986; Bagga et al., 2003). 
While eicosanoids can participate to some beneficial effects of -3 LC-PUFAs, they cannot 
explain all the protective effects of these PUFAs on cardiac function following CHD and on breast 
cancers. Thus the aim of the present review is to compare the effects of -3 LC-PUFAs on some 
ischemic cardiac dysfunctions and on breast cancer in order to evaluate if some of the beneficial 
effects involve similar signalling pathways. 
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I - EPIDEMIOLOGICAL STUDIES 
At the end of the 1970’s, it has been observed that Inuit population had a lower incidence of 
cardiac diseases than the Dane population (Bang et al., 1976). At the same period, it was observed 
that Japanese women had a lower risk to develop a breast cancer than women in other industrialised 
countries (Buell, 1973, see figure 1A). Also, the incidence of cardiovascular diseases in the 
Japanese population is low (Kagawa et al., 1982). All these observations have been attributed to 
high fish consumption by these populations (Kromhout et al., 1985; Wynder et al., 1986). Rapidly, 
the interest of researchers focused on the possible protective effects of marine -3 LC-PUFAs, 
namely EPA and DHA (see figure 1B). 
 
I-1 – Epidemiological studies on cardiovascular diseases 
The first clinical cardiovascular trial was reported in 1989 (Burr et al., 1989). The authors 
showed that the mortality following myocardial infarction was reduced by 29% after two years in a 
group of men who were advised to eat oily fishes at least twice weekly as compared to others who 
had not received any recommendation. This reduced mortality was not associated with reduced 
ischemic heart disease events or levels of total cholesterol. This suggested anti-arrhythmic effects 
since arrhythmias are likely to be the main cause of sudden death following myocardial infarct. 
More recently, a large prospective, randomized clinical trial of 11324 patients who had had 
a recent myocardial infarction was reported (GISSI, 1999). In this trial, patients were randomly 
assigned to four groups to test the effects of a daily dose of 1) 850 mg EPA plus DHA (inferior to 
the recommendation of 1000 mg per day by the American Heart Association; Kris-Etherton et al., 
2002), 2) 300 mg of α-tocopherol (vitamin E, an anti-oxidant), 3) -3 PUFAs plus vitamin E and 4) 
a control group that received neither fatty acids nor vitamin E. This supplementation was in addition 
to the pharmacological treatment. After 3.5 years, vitamin E did not bring significant benefits while 
-3 LC-PUFAs lowered the risk of cardiovascular death by 17% (2-ways analysis) or 30% (4-ways 
analysis). A 45% reduction in sudden death at 42 months, which started to be significant 4 months 
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after the beginning of the supplementation, was also observed (Marchioli et al., 2002). This latter 
observation strongly suggests that the benefit of -3 LC-PUFAs may not be mediated via 
antiatherosclerotic and antithrombotic effects but very likely involves anti-arrhythmic effects. 
Another prospective randomized trial reported a 50% reduction of the risk of sudden cardiac death 
with higher doses of -3 LC-PUFAs (2 g per day EPA plus DHA) (Singh et al., 1997). 
 
I – 2 Epidemiological studies on breast cancer 
The influence of environmental factors such as diet on breast cancer is an accepted fact 
(Buell, 1973; Word Cancer Research Fund, 1997). Despite the promoting effects of total dietary fat 
on breast tumours, it has been shown that -3 LC-PUFAs were lacking tumour-promoting effects 
(Wynder et al., 1986). Since these pioneer works, many epidemiological studies have been 
undertaken to document further a protective role of -3 LC-PUFAs but they remained inconclusive 
(Willett, 1998). The discrepancy may arise from confounding effects of many compounds such as 
antioxidants or -6 LC-PUFAs which both can be cancer promoting agents (Bougnoux, 1999). 
Above all, it must be underlined that the relative proportion of -3 and -6 LC-PUFAs may be a 
determinant of the effect of -3 LC PUFAs on breast cancer risk (Chajès & Bougnoux, 2003). 
Indeed, a recent European case-control study gave results leading to the hypothesis that -3 LC 
PUFAs inhibit breast cancer, depending on background levels of -6 LC-PUFAs (Simonsen et al., 
1998). 
 
I – 3 Conclusion on epidemiological studies 
From the epidemiological studies, it appears that the cardioprotective effects of fish oil -3 
LC-PUFAs are well determined while the anti-tumoral effects need careful settings and 
characterizations of other components of the diet such as -6 PUFAs and antioxidants levels. These 
differences might be due to the fact that the causality of the disease is well defined in the case of the 
heart (mortality following myocardial infarction) while the etiology of breast cancer is 
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multifactorial. Indeed, it is even critical to recognize that breast cancer is a collection of diseases 
(Debies & Welsh, 2002). 
 
II – EXPERIMENTAL STUDIES 
II – 1 Experimental studies in cardiology 
The first study investigating the possible antiarrhythmic effects of fish oil fatty acids was 
performed in 1988 by McLennan et al. In their experiments, rats were fed diets in which the 
major fat component was controlled. At the end of the 3 months dietary period, they ligated the 
left anterior descending coronary artery of the rats and counted the number of animals that died 
of sustained ventricular fibrillation. They found that, while some rats died of arrhythmias in the 
group receiving sunflower seed oil, no rat died in the group receiving tuna fish oil (rich in -3 
LC-PUFAs). They also reported a similar antiarrhythmic action of the -3 LC-PUFAs in 
marmosets (McLennan et al., 1992). Similar results have been obtained in rats by other 
investigators. 
To investigate a possible direct effect of -3 LC-PUFAs on ischaemia-induced 
ventricular fibrillation, Billman et al. (1999) used another approach to supply the fatty acids. A 
surgically induced anterior myocardial infarction was produced in dogs, and a hydraulic 
inflatable cuff was set around the left circumflex artery so it could be compressed at will. The 
dogs were then trained to run on a treadmill during the month allowed for recovery from the 
surgery. Upon exercise, the coronary occlusion caused about 60% of the dogs to go into a fatal 
ventricular fibrillation within two minutes of the coronary flow stop. The intravenous 
administration of EPA or DHA (free FA) 90 minutes before the exercise reversibly prevented 
fatal ischaemia-induced arrhythmias, confirming the studies of McLennan et al. (1988, 1992).  
However, a difference remains between Billman’s and McLennan’s results. In their work, 
Billman et al. (1999) did not find any difference between the antiarrhythmic effects of EPA and 
DHA in dogs. McLennan et al. (1996) compared the effect of low dose (0.4 – 1.1% of energy 
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intake) of EPA and DHA on rat ischaemia-induced arrhythmias. They found that DHA was able 
to prevent these arrhythmias while EPA was not. The difference between the results could 
originate from the way of administration of the oils: in one experiment, FA were administered in 
the diet while in the other, they were perfused intravenously. An other hypothesis relies on the 
model used. Indeed, it is not obvious that lipid metabolism is the same in rats and dogs. This 
point is a very important one and has to be clarified before extrapolating results obtained in 
animals to observations made in human epidemiological studies. 
 
II – 2 Experimental studies in breast cancer 
Data from experimental studies carried out in animals show that elevated supplies of fish 
oil (rich in EPA and DHA) generally inhibit tumour growth in chemo-induced, transplanted or 
spontaneous mammary tumour models (for a review see Bougnoux, 1999; Rose & Connolly, 
1999).  A meta-analysis by Fay et al. (1997) showed that -3 LC-PUFAs have only a small 
protective effect while -6 PUFAs have a strong tumour-enhancing effect. Like in 
epidemiological studies, the ratio -6/-3 PUFAs seems to be primordial to observe an effect, a 
ratio of 1 being protective while higher ratios are tumour-enhancing (Cohen et al., 1993; Sasaki 
et al., 1998). 
Another aspect of breast cancer is the occurrence of metastases. In models of mammary 
cancer cell lines transplanted into nude mice, it has been observed that EPA and fish oil diet 
supplementation reduced primary tumour growth and metastases occurrence (Senzaki et al., 
1998; Hubbard et al.; 1998). 
 
II – 3 Conclusion on experimental studies 
As in epidemiological studies, the cardioprotective effects of -3 LC-PUFAs appear 
obvious, probably owing to the well-defined models of cardiac disease. In animal models of 
breast cancer, even if the situation is not as clear as it is in cardiac models, the protective role of 
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-3 PUFAs seems very likely but this effect is hampered by the tumour-enhancing effects of -6 
PUFAs and antioxidant also present in the diet. Moreover, it seems that the ratio -6/-3 is more 
important than the mere -3 intake. 
 
III – CELLULAR EFFECTS 
III – 1 Cardiac effects  
At the cellular level, the results obtained on the cardioprotection effects of -3 LC-PUFA 
were mainly obtained by Leaf and collaborators on cultured neonatal rat cardiomyocytes. In 
brief, they found that the arrhythmias produced by high extracellular calcium concentration, 
ouabain, isoproterenol, lysophosphatidylcholine and even the Ca
2+
 ionophore A23187 were 
reversed by EPA (see figure 2). This effect was reversed by the addition of delipidated bovine 
serum albumin to remove free acids from the myocytes. It must be noted that this effect was 
observed with the free acid while the ethyl ester of EPA was ineffective (see Leaf et al., 2003 for 
a review). These results led Leaf's group to hypothesise that the free fatty acid, thanks to its 
carboxylic group, interacts directly with ionic channels to prevent or resorbe lethal arrhythmias. 
 
III – 2 Breast cancer cells 
While the in vivo (epidemiological and experimental) studies did not give strong evidence 
for a beneficial effects of -3 LC-PUFAs against breast cancer, in vitro cell culture experiments 
have led to a consensus that some PUFAs have a selective cytotoxic or anti-proliferative effect 
on tumour cells and no effect on normal cells. However, this consensus has been challenged in a 
recent and pertinent review (Diggle, 2002). Indeed, in studies on MCF-7 cells, Grammatikos et 
al, (1994) showed that the proliferation of these cells was inhibited by µM EPA, but also by AA. 
Such an inhibition was not observed by Chajès et al (1995) but in this latter study, other cell lines 
(MDA-MB-231, HBL-100, ZR-75, T47D) were sensitive to -3 LC-PUFAs. AA was not tested. 
In general, these studies concluded that PUFAs or -3 PUFAs inhibit cell proliferation through 
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the formation of lipid hydroperoxides. However, the careful re-examination of key publications 
by Diggle (2002) shows that the control cells used in these studies were not valid (e.g. fibroblast 
vs epithelial cells). Also, the cytotoxic/anti-proliferative effects induced by both -3 and -6 
PUFAs on different cell types, and associated with an increase in lipid peroxidation, cannot 
account for the in vivo data. This suggests that interaction of PUFAs or their metabolites with 
signalling pathways could explain their in vivo effects. 
 
III – 3 Conclusion on cells 
Whatever the field of research, cardiac or breast cancer, the in vitro experiments on 
isolated cells underline the problem of the model used. In the cardiac field, the cells which have 
been used to reproduce in vivo experiments are rat neonatal cells. There was, to our knowledge, 
no attempt to use an ischaemia-reperfusion model of isolated cells as the one described by 
Maddaford et al. (1999). In the cardiac cultured cell model, the fact that very different ways to 
produce arrhythmias are all sensitive to micromolar EPA, which is thought to act mainly on 
membrane proteins, needs a careful examination of the experimental conditions. 
At that point, this kind of problems applies to cancer cell line models. Indeed, 
lipoperoxidation has been proposed as one of the possible mechanism for cytotoxicity. Lipid 
peroxidation is a free-radical chain reaction that is initiated by reactive oxygen species (ROS). 
ROS are free radicals as well as non radical species (e.g. hydrogen peroxide and singlet oxygen) 
generated by electrons which have leaked (as a natural and normal phenomenon) from the 
mitochondrial electron transport systems. The initial reactive species is the superoxide anion 
which further forms the highly reactive hydroxyl radical (Brand et al., 2004). These ROS are 
normally eliminated by antioxidant enzymes and radical-scavenging lipid antioxidant vitamins 
(such as tocopherols and tocotrienols) or other antioxidant nutrients. However, when these 
enzymes or vitamins are or become unable to cope with an increased ROS production, radicals 
can react with the alkyl chain of fatty acyl moiety of membrane phospholipids. This reaction is 
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facilitated with the degree of unsaturation of the FA leading to oxidized metabolites and 
degradation products such as fatty acid hydroperoxides, isoprostanes, malondialdehyde (see for a 
review Kohen & Nyska, 2002). This initiates the free-radical chain reaction in the membrane at 
various localizations (such as plasmalemmal, mitochondrial, nuclear membranes) and can lead to 
alterations in the functioning of membranes proteins.  
How does lipoperoxidation occur in vivo knowing that pO2 in tumours is very low 
(Runkel et al., 1994)? Moreover, since EPA as free FA reversed arrhythmias induced by many 
different factors in vitro, while the ethyl ester form, which is less peroxidizable, did not, is 
peroxidation necessary? Can lipoperoxidation occur in vivo despite antioxidant protection 
systems? These questions have to be answered before transposing in vivo models to in vitro 
models. Anyway, the knowledge of some mechanisms involved in the development of the 
pathology and their regulation by -3 LC-PUFAs can help to understand some of the beneficial 
effects of these PUFAs. 
 
IV – IONIC CHANNELS 
 Before reviewing the reported effects of -3 LC-PUFAs on ionic channels, we would like to 
suggest another possible membrane target of these lipids, gap-junctions. These proteins are 
channels which permit cell-to-cell communication. It is known that there is a gap junctional 
uncoupling along the course of breast cancer development (Carystinos et al., 2001) and during 
cardiac ischaemia (De Groot & Coronel, 2004). In that latter case, the decreased conductance of 
gap junction is closely related to the occurrence of arrhythmias (De Groot & Coronel, 2004). 
Increasing gap junctional intercellular communication in a breast cancer cell line (MCF-7) was 
associated with a reversal of the cancerous phenotype (Saez et al., 2003). Thus, it is possible that 
any treatment which would increase gap junctional intercellular communication would be 
beneficial in preventing breast cancer development and cardiac ischaemia-induced arrhythmias. 
Up to now, few studies report the effect of -3 LC-PUFAs on gap junctions and none of these 
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concerned breast cancer or cardiac cells. In a colon cancer cell line, Caco-2, Dommels et al. 
(2001) found no effect of cell incubation in presence of EPA while alpha-linolenic acid (C18:3n-
3) reduced gap junctional intercellular communication. In cultured human ombilical vein 
endothelial cells, Zhang et al. (1999) found that cell incubation with EPA was able to prevent 
hypoxia/reoxygenation-induced gap junction dysfunction. This effect was mediated through an 
inhibition of a tyrosine kinase. 
The modulation of gap junctions by -3 LC-PUFAs on breast cancer and cardiac cells 
remains an unexplored field of research and thus would be worthy of study. 
 
IV – 1 -3 LC-PUFA effects on cardiac ionic channels 
Since it has been strongly suggested that -3 LC-PUFAs were anti-arrhythmic, two main 
hypotheses were explored. The first one addresses a possible modulation of ionic channels by 
LC-PUFA. 
In 1995, Kang et al. found that 10 µM EPA stabilised the resting membrane potential, 
increased the threshold to trigger an action potential and prolonged the refractory period 3-fold. 
Based on these results, Leaf’s group proposed that -3 LC-PUFAs exerted these effects through 
the modulation of ion channels activity. They first studied the voltage-gated sodium current (INa). 
They found that it was blocked by micromolar concentrations of LC-PUFAs (Xiao et al., 1995). 
Latter on, they found that asparagine residue 406 in NaV1.5 may be important for the inhibition 
of the current (Xiao et al., 2001). Initially, it was proposed that such a blockade of INa was 
pertinent to the antiarrhythmic actions of -3 LC-PUFAs. Meanwhile, the same group found that 
other currents (ITO, ICaL, IKACh, ICl,AMPc) were also blocked by micromolar doses of EPA or DHA 
(Leaf et al., 2002). Such non-specific effects of EPA and DHA challenge the proposal that -3 
PUFAs interact directly with the ionic channels (Leaf et al., 2002). Membrane tension could be 
altered by FA incorporation leading to changes in ionic channels activity (Andersen et al., 1995). 
Whatever molecular effects of LC-PUFAs on ionic channels, it is quite surprising that EPA, 
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which blocks ICaL (Xiao et al., 1997), does not affect cardiac cell contraction (Kang & Leaf, 
1996). Ferrier et al. (2002) formulated the same remark and explained this apparent discrepancy 
by the existence of a voltage-sensitive release mechanism (VSRM) of calcium which would be 
insensitive to -3 LC-PUFAs. However, the existence of the VSRM is not generally accepted 
(Brette et al., 2003). Also, Negretti et al. (2000) found a negative inotropic effect of EPA which 
they attributed to the blockade of ICaL. Pepe et al. (1994) reported that 5 µM DHA did not affect 
ICaL amplitude or cell contraction. These contradictory results and the non-specific effects of 
EPA and DHA on ionic channels, led to another hypothesis based on oxidative properties of LC-
PUFAs. Indeed the double bonds of -3 LC-PUFAs render them very sensitive to the oxidative 
status of the environment. In this context, Judé et al. (2003) showed that the prevention of 
lipoperoxidation of DHA by vitamin E in the physiological saline solution counteracts the 
blocking effect on ITO of DHA and of DHA plus H2O2 (figure 3). These authors came to the 
conclusion that DHA has no effect on ionic channels. Rather, a product of its peroxidation 
(physiological or not) is responsible for the effects. Therefore, and since the GISSI trial (1999) 
clearly showed no additional effect of vitamin E on post-infarction mortality, the systematic use 
of an antioxidant in the perfusion medium could help to discriminate between specific and non-
specific effects. 
In conclusion, the sensitivity of some ionic channels to -3 LC-PUFAs might participate 
in their antiarrhythmic properties. It is plausible that sodium channels are sensitive to -3 LC-
PUFAs since animal experiments (McLennan et al., 1992) and cultured cell experiments (Kang 
et al., 1995) respectively showed that the fibrillation and action potential threshold were 
increased by these FA. For other currents such as ICaL, further experiments are needed. 
 
IV – 2 Ionic channels in breast cancer 
If -3 LC-PUFAs can modulate the activity of some ionic channels and be healthy 
through this pathway, the role of ionic channels has to be defined in breast cancer. 
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Since 1994 and the seminal work of Marino et al., there are more and more evidence that 
increased potassium channels activities are associated with increased proliferation rates in 
different breast cancer cell lines (Woodfork et al., 1995). The channels involved are ATP-
sensitive channels (Woodfork et al., 1995), Ca
2+
-activated channels (Wegman et al., 1991; 
Ouadid-Ahidouch et al, 2004a,b; Roger et al., 2004b), voltage-activated Kv1.1 channels 
(Ouadid-Ahidouch et al., 2000) and EAG K
+
 channels (Ouadid-Ahidouch et al., 2001). The 
mechanisms of action of these channels are unknown but it has been proposed that they act 
through the changes in membrane potential (Wang et al., 1998). The activation of K
+
 channels 
allows the G1 to S cell cycle transition (Strobl et al., 1995). Such a hypothesis has been 
developed after it was observed that the normal proliferation of T lymphocyte was regulated by 
the Kv1.3 channel activity (Chandy et al., 1984). 
Recently, it has been observed in tumour biopsies that about 50% of breast cancers were 
associated with the expression of Task-3, a double-pore domain K
+
 channel (Mu et al., 2003). 
The molecular role of this channel is unknown but it has been shown to confer a resistance to 
hypoxia and serum deprivation on cancerous cells. 
All these channels are expressed in various normal tissues where they play roles which 
are not necessarily involved in cell proliferation, such as presynaptic excitability of 
glutamatergic synapse for BKCa (Hu et al., 2001), insulin secretion for K,ATP (Petersen & 
Dunne, 1989). In these native structures or in expression vectors, these channels have been 
challenged to different fatty acids. Some of them are sensitive to different kinds of PUFAs. For 
example, the Kv1.1 which has been reported to participate in cancer cell proliferation (Ouadid-
Ahidouch et al., 2000), has recently been found to be tightly regulated by AA and PIP2 (a 
phospholipid rich in LC-PUFAs) (Oliver et al., 2004). K,ATP, the first potassium channels 
described as being involved in breast cancer cells proliferation (Woodfork et al., 1995) are 
activated by AA through the production of prostanoids in rat aorta (Engler et al., 2000). Since 
dietary -3 LC-PUFAs substitute for AA in membrane phospholipids, it can be hypothesised 
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that -3 LC-PUFAs reduce available AA, therefore indirectly reducing K,ATP activity in 
cancerous cells. In turn, this would reduce cell proliferation. 
BKCa also is known to be regulated by unsaturated fatty acids. These effects can be 
indirect (sensitivity of the channel to metabolites such as prostanoids or through modulation of 
intracellular calcium homeostasis) but it has also been proposed that these effects can be direct. 
Denson et al. (2000) compared the effects of different FAs on BKCa channels of pituitary 
adenoma cells (GH3). They found that IBKCa is increased proportionally to the number of double 
bonds of the FA. The authors proposed that there is a direct interaction between the FA and the 
channel protein on the cytosolic surface of the membrane which alters the Ca
2+
 sensitivity of the 
channel. However, such an effect on breast cancer cells would increase proliferation according to 
the “membrane potential” hypothesis.  
A blockade of EAG channels has been shown to reduce cell proliferation (Ouadid-
Ahidouch et al., 2001). Conversely, blockade of hERG channel, the cardiac homologue of EAG, 
leads to arrhythmias (see Champeroux et al., 2000).  Also, inhibition of Task-3 channels in breast 
cancer cells inhibits proliferation (Pei et al., 2003) but the activation of Trek-1, another double-
pore domain protein channel, is antiarrhythmic (Aimond et al., 2000; Judé et al., 2003). Thus, it 
is unlikely that -3 LC-PUFAs exert their beneficial effects through these targets.  
 
IV – 3 Comparison of cardiac and breast cancer cell ionic channels 
If we compare the role of ionic channels, and their sensitivity to -3 LC-PUFAs, in 
breast cancer cell proliferation and cardiac arrhythmias, there is no obvious candidate which 
could participate in the beneficial effect of these FA. It even seems that, according to their 
sensitivity to -3 LC-PUFAs, their roles are antagonistic with regard to protection.  
The involvement of ionic channels in invasion of basement membrane by cultured cells, 
another aspect of cancer which reflects the beginning of the metastatic process, has been less 
explored. This is of great importance since mortality is related to the development of metastases. 
 15 
It has been shown that the loss of a Ca
2+
-activated chloride channel (CLCA2) occurs in some 
metastatic breast cancers (Gruber & Pauli, 1999). This channel is thus considered as a tumour-
suppressor. More recently, a voltage-gated sodium current has been described in a very invasive 
breast cancer cell line, MDA-MB-231 (Roger et al., 2003). This current participates in the 
invasivity through mechanisms which do not seem to involve action potentials. It is blocked by 
micromolar concentrations of tetrodotoxin (TTX) which designates the protein as TTX-resistant. 
As suggested initially by Roger et al. (2003), the isoform of the channel is the cardiac NaV1.5 
(figure 4). Since it has been reported that a fish diet reduces the occurrence of metastases 
(Hubard et al., 1998) and that some of the antiarrhythmic effects of EPA and DHA involve an 
inhibition of the cardiac sodium current (Xiao et al., 2001), it is tempting to speculate that -3 
LC-PUFAs can block the sodium current in breast cancer cells expressing the protein, avoiding 
or at least delaying the development of metastases. We thus performed preliminary experiments 
to evaluate the chronic effects of micromolar doses of DHA on INa in MDA-MB-231 cells. We 
found a significant reduction of the current amplitude but the results need to be confirmed. It 
must be underlined that this channel protein is found both in cardiac and breast cancer cells. Its 
blockade can be beneficial in the treatment of arrhythmias and perhaps in the treatment of some 
breast cancers (see Roger et al., 2004a). Also, this channel can be regulated by kinases such as 
LC-PUFAs-regulated PKCs. The link between sodium channels, invasion and ischaemia-
reperfusion-induced arrhythmias might be the Na
+
-H
+
 exchanger. Indeed, it has been shown in a 
cancer cell line (MCF-7) that a lysophospholipid analog, which inhibits proliferation, reduced 
the activity of the exchanger leading to cytoplasmic acidification (Besson et al., 1996). Likewise, 
it has been proposed that EPA and DHA inhibit the Na
+
-H
+
 exchanger which could account for 
their cardioprotective effects (Goel et al., 2002).  
 
V – PROTEIN KINASES C 
The regulation of PKCs by different factors like phosphatidylserine (PS), Ca
2+
, 
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DiAcylGlycerol (DAG) is well known. The PKCs are presently divided into three sub-families 
based on the homology in the regulatory domain and their activating ligands. The classical PKC 
(cPKC) isozymes (, I, II, ) are activated by the second messengers Ca2+ and DAG in the 
presence of PS. The novel PKCs (nPKC) (, , , ) are activated by DAG in the presence of PS 
but are insensitive to Ca
2+
. Both types of PKCs are activated by the tumour-promoting phorbol 
ester PMA. The third sub-family, the atypical PKCs (aPKCs) (, , , ) are not activated by 
PMA, DAG or Ca
2+
.  Each PKC isozyme localises to unique subcellular sites upon stimulation of 
cardiac myocytes. This suggests that the various PKC isozymes mediate unique functions 
(Mackay & Mochly-Rosen, 2001). Also, taking as example one specific target of PKCs, the 
cardiac calcium channel CaV1.2, different PKC isozymes were shown to regulate its function 
depending on its cellular location: channels in T-tubules may be regulated by PKC while 
channels in the plasma membrane may be regulated by PKCII (see Dorn & Mochly-Rosen, 
2002). 
In a pioneer work, Bordoni et al. (1991) suggested that the fatty acid composition of the 
DAG produced by the 1-stimulated phosphoinositide breakdown influences the pattern of 
activation of protein kinase C. More recently, Madani et al. (2001) showed that the PUFA 
composition of the DAG is responsible for a differential activation of different isoforms of 
PKCs, namely PKC, PKC and PKCI. 
 Knowing that PKCs are involved in both breast cancer and ischaemia-induced arrhythmias, 
it is of great interest to compare the mechanisms in both diseases to highlight the possible 
common features. 
 
 V – 1 Involvement of PKCs in ischaemia-induced arrhythmias 
Since 1990, it is known that 1-adrenoceptors are implicated in myocardial ischaemic damage 
(Corr et al., 1990). Early after, since ischaemia-reperfusion is associated with increased levels in 
myocardial IP3, Du et al. (1995) modulated the level of IP3 during reperfusion with blockers such 
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as gentamicin or prazosin and found a close correlation between the release of IP3 and 
arrhythmias occurring after reperfusion. These works initiated numerous studies on the effect of 
PUFA supplementation on ischaemia-reperfusion-induced IP3 release. 
 Woodcock et al. (1995) showed that supplementing diet for 8 weeks with oils enriched with 
-3 LC-PUFAs reduced noradrenaline-stimulated IP3 release. They concluded that individual 
inositol phosphate isomers can affect the inositides metabolism. Soon after, the same group 
showed that in rats fed fish-oil-supplemented diet, the incorporation of -3 LC-PUFAs into 
cardiac membrane phospholipids was associated with a significant reduction of reperfusion-
induced rise in IP3 and arrhythmias as compared to a control group of rats fed -6 LC-PUFAs or 
saturated fatty acids. For these authors, the inhibition of reperfusion-induced rises in IP3 by -3 
LC-PUFAs after fish oil supplementation provided a possible mechanism for the inhibitory 
effect of -3 LC-PUFAs on reperfusion-induced arrhythmias. Similarly, Nair et al. (2000) 
showed that in pigs fed diets supplemented with fish oil, stimulated cardiac cells had lower 
levels of IP3 compared to those isolated from pigs fed diets supplemented with beef tallow. This 
is of interest since the physiology of pig heart is comparable to that of human heart. 
 In accordance with the previous results, Reithmann et al. (1996) found similar results in 
cultured neonatal rat cardiomyocytes incubated for 3 days in presence of 60 µM DHA. The 
reduced release of IP3 was not due to reduced density of 1-receptors or reduced concentration of 
PIP2.  
If IP3 metabolism is altered during ischaemia, it is very likely that PKC activity is also 
changed in such a situation. Indeed, Strasser et al. (1999) showed that PKC activity was 
increased in ischaemic rat heart. More precisely, they showed that acute (1 minute) ischaemia led 
to the translocation of PKC, PKC, PKC and PKC isoforms to the particulate fraction and that 
prolonged ischaemia (60 minutes) increased total PKC activity associated with isozyme-specific 
induction of PKC and PKC. Later on, Tölg et al. (2001) showed that activation of PKCs is 
necessary to observe ischaemia-induced arrhythmogenesis. They did not test for the involvement 
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of specific PKC isoforms, especially PKC and PKC. PKC is thought to be deleterious while 
PKC has been shown to exert beneficial effects particularly in the preconditioning phenomenon. 
Preconditioning describes the fact that short periods of ischaemia just prior to prolonged 
ischaemia reduce cardiac damage by prolonged ischaemia in vivo and in vitro (Cohen et al., 
2000). Since the activation of PKC participates in this phenomenon, it can be proposed that 
PKC activation by -3 LC-PUFA could participate in their cardioprotective effects. 
 
 V – 2 Involvement of PKCs in breast cancer 
The involvement of PKCs in the development of breast cancer has been suggested a long time 
ago and PKCs have even been proposed to serve as markers of this disease (see MacKay & 
Twelves, 2003 for a review). Since then, the involvement of PKCs in mammary carcinogenesis 
has been extensively studied but did not dramatically increase our knowledge.  
PKCs are known to be involved in proliferation, estrogen-sensitivity, apoptosis and 
metastasis. The involvement of PKCs in such a variety of biological phenomena may be 
explained in part by the expression of different isoforms in breast tissue and the possibility that 
each isoform selectively phosphorylates different target proteins which mediate different 
biological responses (Kiley et al., 1996). 
Up to now, the PKCs of interest in breast cancer are PKC and PKC which are recognised 
to be involved respectively in proliferation (Lahn et al., 2004) and metastasis (see Debies & 
Welsh, 2002). In both cases, the fact that these PKCs are upregulated led to develop specific 
isoform inhibitors which are presently tested in clinical trials (see MacKay & Twelves, 2003; 
Lahn et al., 2004). 
The signalisation pathways have been described in the other above-cited reviews and are out 
of the scope of the present one. The important point is to underline that PKC and PKC are both 
probably involved in some oncogenic signalisation pathway. 
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 V – 3 Comparison of the role of PKCs in breast cancer and heart 
To conclude on the role of PKCs in ischaemia-induced arrhythmias and in breast cancers, we can 
say that in both cases, these kinases are up-regulated. Interestingly, some isoforms are involved 
in different aspects of both diseases. PKC is activated in the early phase of cardiac ischaemia 
and is involved in breast cancer cell proliferation. PKC is activated in chronic ischaemia phase 
(see also Chen et al., 2001) and is involved in metastasis. These isoforms are good candidates to 
the modulation of their activity by different molecular species of DAG as shown by Madani et al. 
(2001). It is thus reasonable to propose that the sensitivity of PKC and PKC to the FA 
composition of DAG participates in -3 LC-PUFAs beneficial properties on breast cancers and 
CHD. 
 
VI – CALCIUM HOMEOSTASIS 
Ca
2+
 is a second messenger which is finely regulated. However, it has also been shown that, 
in physiopathological situations, it is involved in the genesis of arrhythmias and in the control of 
cell proliferation. As such, it is of interest to see how -3 LC-PUFAs interfere with the Ca2+ 
homeostasis of cardiac and breast cancer cells. 
 
VI – 1  Calcium and -3 LC-PUFAs in cardiac cells 
In 1993, Taffet et al. have shown that feeding rats an -3 LC-PUFAs diet increased the 
incorporation of DHA, at the expense of AA, in sarcoplasmic reticulum (SR) phospholipids. This 
effect was associated with a lower Ca
2+
 loading of the SR and a decreased activity of the SR 
Ca
2+
-ATPases. Later, Xiao et al. (1997) found that EPA, which inhibits ICaL in rat 
cardiomyocytes, reduced the amplitude of the calcium transient. This effect was attributed to the 
decreased amplitude of ICaL since the characteristics of Ca
2+
 sparks were not changed. This 
suggested a lack of effect on RYR2, the SR calcium channel. In the same type of cells, Negretti 
et al. (2000) found a decreased resting calcium concentration associated with lower spontaneous 
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SR releases of Ca
2+
. This might be attributed to a reduced entry of Ca
2+ 
through the calcium 
channels but it does not explain the increase in SR calcium load (Negretti et al., 2000). The 
authors explained the phenomenon by an inhibition of the release mechanism, possibly on 
RYR2. The decreased resting intracellular calcium concentration is rather difficult to reconcile 
with the slower relaxation of the calcium transient in cells from rat fed -3 LC-PUFAs (Leifert 
et al., 2001). This later result is however compatible with the recent inhibition of the Na-Ca 
exchanger found by Xiao et al. (2004). 
 In summary, the results are contradictory at the molecular level. But all studies showed that 
the calcium homeostasis is modified in cells perfused with PUFAs and in rats fed fish oil. The 
modifications observed are in agreement with an antiarrhythmic effect of -3 LC-PUFAs. 
Indeed, increases in cytoplasmic Ca
2+
 levels, and sensitisation of RYR2 to Ca
2+
 are both 
associated with spontaneous Ca
2+
 release which, through the initiation of an inward INaCa, can 
trigger extrasystoles. These spontaneous contractions, typical of isolated rat cells, are inhibited 
by -3 LC-PUFAs. 
 
VI – 2  Calcium and -3 LC-PUFAs in mammary epithelial cancer cells 
In human mammary epithelial cells, the homeostasis of Ca
2+
 is of importance for cells but the 
regulations are very different from those in cardiac cells. The intracellular stores of calcium 
(endoplasmic reticulum, ER) can release calcium mainly following the IP3 increase (IP3-induced 
calcium release, Patel & Schrey, 1992) while in heart cells the calcium release is induced by the 
elevation of cytoplasmic Ca
2+
 (Ca
2+
-induced calcium release, Fabiato, 1985). The release of Ca
2+
 
can occur thanks to the activity of a thapsigargine-sensitive Ca
2+
-ATPase responsible for the 
loading of the store (Serguev & Rhoten, 1998). In a study, performed on BT-20 cells, Serguev & 
Rhoten suggested the existence of voltage-insensitive Ca
2+
 channels but did not find the evidence 
of capacitive Ca
2+
 entry. 
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 The physiological role of intracellular calcium seems to rely mainly on transcription, 
enzyme activation and regulation of apoptosis but the precise pathways are not known. However, 
an increase in intracellular calcium is clearly associated with an increased proliferation 
(Tannheimer et al., 1997; Roger et al., 2004b). This increased proliferation might be consecutive 
to the MAPK activation as shown in MCF-7 cells (Improto-Brears et al., 1999). Conversely, 
hormones like 1,25(OH)2D3 which inhibit breast tumour growth, induce the emptying of 
intracellular Ca
2+
 pools and increase apoptosis (Vandewalle et al., 1995). EPA also has been 
shown to inhibit capacitive calcium influx in different cancer cell lines (e.g. cervix, liver, 
glioblastoma, breast), leading to the emptying of the ER (Palakurthi et al., 2000). This effect, 
which was antagonized by vitamin E, suggesting the involvement of peroxidation, was 
associated to a reduced proliferation. 
 
VI – 3  Conclusion on calcium and -3 LC-PUFAs  
In both kinds of cells, calcium is important to their physiology. Increased cytosolic Ca
2+
 is 
arrhythmogenic in cardiac cells and filling of the ER with Ca
2+
 enhances proliferation in 
mammary epithelial cells. An apparent beneficial effect of -3 LC-PUFAs has been reported but 
at the molecular level, contradictory results were obtained. To simplify the role of Ca
2+
, 
increasing cytosolic Ca
2+
 concentration is deleterious and any attempt to reduce it, e.g. with -3 
LC-PUFAs, might be beneficial. 
The results published by Palakurthi et al. (2000) on cancer cells underline the role of 
peroxidation. Lipoperoxidation cannot be avoided if antioxidants are not used. Therefore, 
experiments studying the effects of -3 LC-PUFAs should be performed in controlled redox 
conditions. 
 
VII – MATRIX METALLOPROTEINASES 
 Matrix metalloproteinases (MMPs) are enzymes which are implicated in physiological 
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(wound healing, angiogenesis, development, etc.) and physiopathological processes such as 
cancer and myocardial infarction. These proteases can be modulated by -3 LC-PUFAs. 
 Very recent reviews describe the regulation of MMPs and their involvement in diseases 
(Egeblad & Werb, 2002; Bartsch et al., 2003; Jones et al., 2003; Lindsey, 2004) and we will only 
give a rapid overview of MMPs. MMPs are a family of zinc-dependent endopeptidases capable 
of cleaving extracellular matrix components. They comprise more than 25 individual members 
divided into specific classes based on in vitro substrate specificity for various extracellular 
matrix components: collagenases (MMP1, MMP8, MMP13), gelatinases (MMP2, MMP9), 
stromelysines (MMP3, MMP7, MMP10, MMP11), metalloelastases ((MMP12) and membrane-
type matrix metalloproteinases (MMP14, MMP15, MMP16, MMP17, MMP24, MMP25). 
MMPs are regulated at multiple levels such as transcription, translation, secretion and their 
activation, which requires calcium, is rather complex (see Egeblad & Werb, 2002; Jones et al., 
2003 for details). It is important to notice the existence of tissue-specific inhibitors of 
metalloproteinases (TIMP-1, TIMP-2, TIMP-3 and TIMP-4). 
 
VII – 1  MMPs in heart diseases 
Activation of MMPs has been shown to occur following myocardial infarction (MI). They are 
involved in ventricles remodelling leading to heart failure, as well as in neovascularisation. 
While different MMPs and TIMPs are regulated following long term remodelling, which is out 
of the scope of the present paper, it however seems that MMP9 and TIMP-1 are upregulated in 
the hours following MI (see Jones et al., 2003 for review). Blankenberg et al. (2003) found that 
plasma levels of MMP9 were closely correlated to mortality in patients with CHD. But, since 
TIMP-1 is also elevated following acute coronary syndrome, it is more important to measure 
MMPs activities than their levels. 
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VII – 2  MMPs in breast cancers 
The expression and activation of MMPs is increased in almost all human cancers compared 
with normal tissue. They are implicated in migration, invasion, metastasis and tumour 
angiogenesis. Thus, they are potential targets for therapies (Egleblad & Werb, 2002).  
 It is generally admitted that MMPs are produced by tumour stromal cells such as fibroblasts 
but Bartsch et al. (2003) found that different MMPs including MMP2 and MMP9 are expressed 
by some tumour cell lines (the level of expression depending on experimental conditions) but not 
by a normal breast epithelial cell line. 
 
VII – 3  MMPs and -3 LC-PUFAs 
In 1993, Rose & Connolly found that dietary -3 LC-PUFAs inhibited the growth and metastasis 
of transplanted MDA-MB-435 human breast cancer cells in athymic nude mice. The invasion 
capacity of the cells, evaluated in vitro, gave similar results when the cells were incubated with 
EPA and DHA (Connolly & Rose, 1993). The authors suggested that these effects were mediated 
through eicosanoid synthesis. 
 Using similar cancer cell transplantation in nude mice model, Suzuki et al. (1997) showed 
that the inhibition of lung metastasis of a colon cancer cell line by EPA and DHA was associated 
with a reduced activity of MMP9 while MMP2 activity was not affected by the presence of these 
PUFAs in the diet. The effect on metastasis was negatively correlated to the concentration of AA 
in the tumour tissue. Such a reduction in MMP9 activity was found by Harris et al. (2001) in 
uterus, placenta and liver tissues of rat fed diets enriched with DHA. They also found a 
decreased activity of MMP2. They explained their finding by a competition of the -3 LC-
PUFAs with AA for incorporation into membrane phospholipids. This would consequently 
change the production of prostaglandin PGE2 (an AA metabolite produced by cyclooxygenase) 
and affect MMP activities. 
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 In the cardiac field, the only study we are aware of describes that EPA inhibits hypoxia-
reoxygenation-induced lactate deshydrogenase release, a marker of cardiac injury (Chen et al., 
2003). They found, on isolated rat cardiac cells, that the beneficial effects of EPA were 
associated with a reduced expression and activity of MMP-1. They observed that lipid 
peroxidation was reduced in EPA treated cells and inferred that peroxidation was a key factor.  
They did not evaluate the activities of other MMPs. 
 It thus seems that MMPs are involved in both breast cancers and CHD. The situation is very 
complex owing to the number of MMPs and the regulation of their expression and activity. The 
activity of MMP2 and MMP9 is increased in both pathologies and can be reduced by -3 LC-
PUFAs. This makes them possible candidates to explain the beneficial effects of fish oil, either 
directly or indirectly through other PUFAs-sensitive regulators (e.g. Ca
2+
, PKCs).  
 
VIII – GENERAL CONCLUSION 
To conclude, we can say that -3 LC-PUFAs can act at very different levels of the cellular 
physiology (see figure 5). Some of the sensitive pathways are cell-type specific but others are 
shared. On this base, we think that the comparison of the cellular effects of -3 LC-PUFAs on 
cardiac cells and breast cancer cells can help to better understand some of their mechanisms of 
action. Recent reviews describe possible specific targets of -3 LC-PUFAs in heart (Das, 2000) 
and cancers (Siddiqui et al., 2004).  
What is the plasma level of -3 LC-PUFAs? It is difficult to answer this question since there 
are no attempts, to our knowledge, to quantify precisely these PUFAs in different dietary 
conditions. In their study on rat cardiac cells, Negretti et al. (2000) estimated the free fatty acid 
concentration in the plasma to be between 8 and 32 µM.  
One difficulty in understanding the molecular effects of -3 LC-PUFAs relies on the quality 
of the models. While the pathological situation in which beneficial effects of -3 LC-PUFAs are 
observed is well defined in the heart (CHD), no study used a corresponding model at the cellular 
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level. Breast cancers have multifactorial etiologies and the conditions in which the effects of -3 
LC-PUFAs are beneficial are far to be delineated. Another difficulty which appears when 
studying cancer, is to identify what is linked to the cancer phenotype and what is not, because 
few comparisons are made with non-cancerous cells (Diggle, 2002). For example, more and 
more publications report the expression of ionic channels in cancer cells but their role in 
pathological proliferation and invasion is not clearly linked to the cancer phenotype. This might 
be due to the fact that few of them challenge normal cells.  
PKCs are among the best candidates as targets of -3 LC-PUFAs. The PKCs of interest 
seem to be PKC and PKC but we cannot exclude that other PKCs are also involved. At that 
point of the discussion it must be underlined that experiments generally focus and observe a 
change in various activities (Ca
2+
, PKCs, ionic channels, MMPs) but some of them are linked. 
For example, PKC is upregulated in some breast cancers. Depletion in intracellular Ca
2+
 stores 
is associated to reduced proliferation thus, since PKC is Ca
2+
 dependent, we can imagine that its 
activity would be decreased in presence of EPA or DHA because of the reduction of cytosolic 
calcium.  
One major concern remaining in these studies is the very nature of the molecules (FA or 
derivatives) which actually exert the -3 LC-PUFAs beneficial effects. Is lipid peroxidation a 
result of uncontrolled experimental conditions? Does peroxidation occur to the same extent in 
situ as it does in cellular models? Do the lipids need to be first peroxidized in order to be active? 
These points are of great importance to better understand the effects of -3 LC-PUFAs on 
health. 
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Figure 1. A, Repartition of women breast cancer incidence in the world. Incidence values are given 
per 100000 women. From Globocan, 2000. (see 
http://www.inctr.org/publications/2002_v03_n01_s02.shtml. Valid on Jan. 4
th
, 2005). B, 2D 
(left) and 3D (right) structures of DHA. The coloured balls correspond to atoms as follows: gray, 
carbon; blue, hydrogen; red, oxygen.  
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Figure 2: Prevention and termination of arrhythmias by EPA. Traces show the shortening of 
cultured neonatal cardiac rat myocytes. Perfusion with medium containing 7 mM Ca
2+
 (A,a) or 
100 µM ouabain (B,a) induced contracture and tachyarrhythmias. Cells washed with medium 
containing 1.2 mM Ca
2+
 returned to their original beating rate (not shown). Myocytes were then 
perfused with medium containing 7 µM EPA. When beating rate had slowed, addition of 7 mM 
Ca
2+
 (A,b) or 100 µM ouabain (B,b) failed to induce contractures or tachyarrhythmias. Beating 
rates, slowed by EPA, returned to original by perfusion with albumin (not shown). C, 
tachyarrhythmias were induced by ouabain (100 µM) plus Ca
2+
 (5 mM) in perfusing medium. 
Addition of EPA (8 µM) terminated tachyarrhythmias. Subsequent addition of delipidated BSA 
2 mg/ml, still in presence of ouabain and high Ca
2+
 concentrations extracted free EPA and 
tachyarrhythmias resumed. From Kang & Leaf, 1994. 
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Figure 3. Comparison of the effects of 10 µM DHA alone, in presence of 1 µM H2O2 or of 1 µM 
vitamin E (-tocopherol) on ITO (A) and ISS (A, B). A, effects of DHA alone (a), in presence of an 
anti-oxidant (-tocopherol) (b) or a pro-oxidant (H2O2) (c) on ITO-V relationship. B, Increasing the 
oxidative status of the Tyrode perfusing solution is associated with a larger effect of DHA on ITO (a) 
and ISS (b). Currents are expressed as mean ± SEM after normalization to current in plain Tyrode 
A B 
 42 
solution. All the means are significantly different from each other (P < 0.05). Bc, Concentrations of 
unperoxidized DHA in the different experimental conditions vs theoretical concentration. Initial: 
theoretical DHA concentration; Anti-oxidant = vitamin E; Pro-oxidant = hydrogen peroxide. From 
Judé et al., 2003. 
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Figure 4. MDA-MD-231 invasive breast cancer cells express voltage-gated sodium channel. A, the 
inward current is triggered by a 30-ms depolarisation from –100 mV to –5 mV and is sensitive to 
external sodium. B, the sodium current is sensitive to micromolar concentrations of TTX. C, RT-
PCR showing that the protein carrying the current is the NaV1.5 since it is the only TTX-R mRNA 
expressed (TTX-R are in bold). A and B from Roger et al., 2003. 
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Figure 5. Schematic cell showing the different pathways which can be affected by -3 LC-PUFAs. 
Specific components of cardiac cells are shown in red, of breast cancer cells in black and common 
components in green. Asterisks indicate the reported targets (direct or indirect) of -3 LC-PUFAs 
in cardiac cells (red asterisks), cancer cells (black asterisks) and both kinds of cells (green 
asterisks). 
